105 related articles for article (PubMed ID: 21907802)
1. Thermal degradation of amorphous glibenclamide.
Rehder S; Sakmann A; Rades T; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):203-8. PubMed ID: 21907802
[TBL] [Abstract][Full Text] [Related]
2. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
[TBL] [Abstract][Full Text] [Related]
3. Study of the amorphous glibenclamide drug: analysis of the molecular dynamics of quenched and cryomilled material.
Wojnarowska Z; Grzybowska K; Adrjanowicz K; Kaminski K; Paluch M; Hawelek L; Wrzalik R; Dulski M; Sawicki W; Mazgalski J; Tukalska A; Bieg T
Mol Pharm; 2010 Oct; 7(5):1692-707. PubMed ID: 20669906
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a Glibenclamide Cocrystal: Full Spectroscopic and Thermal Characterization.
Silva Filho SF; Pereira AC; Sarraguça JMG; Sarraguça MC; Lopes J; Façanha Filho PF; Dos Santos AO; da Silva Ribeiro PR
J Pharm Sci; 2018 Jun; 107(6):1597-1604. PubMed ID: 29432762
[TBL] [Abstract][Full Text] [Related]
5. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
[TBL] [Abstract][Full Text] [Related]
6. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
J Pharm Sci; 2005 Sep; 94(9):1998-2012. PubMed ID: 16052554
[TBL] [Abstract][Full Text] [Related]
7. New solid modifications of nateglinide.
Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Lanfranconi S; Marini A
J Pharm Biomed Anal; 2010 Apr; 51(5):1054-9. PubMed ID: 20022441
[TBL] [Abstract][Full Text] [Related]
8. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thermal stability of indinavir sulphate using diffuse reflectance infrared spectroscopy.
Singh P; Premkumar L; Mehrotra R; Kandpal HC; Bakhshi AK
J Pharm Biomed Anal; 2008 Jun; 47(2):248-54. PubMed ID: 18280078
[TBL] [Abstract][Full Text] [Related]
10. Differential scanning calorimetry predicts the critical quality attributes of amorphous glibenclamide.
Mah PT; Laaksonen T; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Sci; 2015 Dec; 80():74-81. PubMed ID: 26296864
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
[TBL] [Abstract][Full Text] [Related]
12. Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials.
Song M; Liebenberg W; De Villiers MM
Pharmazie; 2006 Apr; 61(4):336-40. PubMed ID: 16649550
[TBL] [Abstract][Full Text] [Related]
13. [Advances in the quantitative analytical methods of drug polymorphism].
Ma LW; Du W; Zhao CS
Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
[TBL] [Abstract][Full Text] [Related]
14. A new polymorph of isoimperatorin.
Fu J; Dong X; Yin X; Yang C; Wang W; Du X; Zhang X; Ni J
Pharm Dev Technol; 2018 Nov; 23(9):849-856. PubMed ID: 27808578
[TBL] [Abstract][Full Text] [Related]
15. Morphological and Physicochemical Evaluation of Two Distinct Glibenclamide/Hypromellose Amorphous Nanoparticles Prepared by the Antisolvent Method.
Yonashiro H; Higashi K; Morikawa C; Ueda K; Itoh T; Ito M; Masu H; Noguchi S; Moribe K
Mol Pharm; 2018 Apr; 15(4):1587-1597. PubMed ID: 29502422
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterisation of a new insoluble polymorphic form of glibenclamide.
Panagopoulou-Kaplani A; Malamataris S
Int J Pharm; 2000 Feb; 195(1-2):239-46. PubMed ID: 10675701
[TBL] [Abstract][Full Text] [Related]
17. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
18. Stress degradation studies of nelfinavir mesylate by Fourier transform infrared spectroscopy.
Singh P; Mehrotra R; Bakhshi AK
J Pharm Biomed Anal; 2010 Nov; 53(3):287-94. PubMed ID: 20399586
[TBL] [Abstract][Full Text] [Related]
19. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
20. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
